GB2392839A8 - Use of Mycobacterium w in the treatment of tubercolosis - Google Patents

Use of Mycobacterium w in the treatment of tubercolosis

Info

Publication number
GB2392839A8
GB2392839A8 GB0400094A GB0400094A GB2392839A8 GB 2392839 A8 GB2392839 A8 GB 2392839A8 GB 0400094 A GB0400094 A GB 0400094A GB 0400094 A GB0400094 A GB 0400094A GB 2392839 A8 GB2392839 A8 GB 2392839A8
Authority
GB
United Kingdom
Prior art keywords
tubercolosis
mycobacterium
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0400094A
Other versions
GB0400094D0 (en
GB2392839A (en
Inventor
Bakulesh Mafatal Khamar
Rajiv Indravadan Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB0400094D0 publication Critical patent/GB0400094D0/en
Publication of GB2392839A publication Critical patent/GB2392839A/en
Publication of GB2392839A8 publication Critical patent/GB2392839A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0400094A 2002-03-08 2003-03-04 Use of Mycobacterium w in the treatment of tuberculosis Withdrawn GB2392839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN235MU2002 2002-03-08
PCT/IB2003/000802 WO2003075825A2 (en) 2002-03-08 2003-03-04 The method of treating tuberculosis

Publications (3)

Publication Number Publication Date
GB0400094D0 GB0400094D0 (en) 2004-02-04
GB2392839A GB2392839A (en) 2004-03-17
GB2392839A8 true GB2392839A8 (en) 2004-11-18

Family

ID=27799867

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0400094A Withdrawn GB2392839A (en) 2002-03-08 2003-03-04 Use of Mycobacterium w in the treatment of tuberculosis

Country Status (4)

Country Link
KR (1) KR20050008452A (en)
AU (2) AU2003209534A1 (en)
GB (1) GB2392839A (en)
WO (2) WO2003075825A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
GB2442408B (en) * 2005-04-25 2010-06-30 Cadila Pharmaceuticals Ltd Mycobacterium W as an adjuvant
AU2007323134B2 (en) * 2006-11-23 2013-05-02 Cadila Pharmaceuticals Limited Poly-TLR antagonist
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION
GB2400560A (en) * 2002-01-29 2004-10-20 Rajiv Indravadan Modi Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals

Also Published As

Publication number Publication date
GB0400094D0 (en) 2004-02-04
AU2003208505A1 (en) 2003-09-29
GB2392839A (en) 2004-03-17
KR20050008452A (en) 2005-01-21
WO2003075825A2 (en) 2003-09-18
WO2003077829A2 (en) 2003-09-25
AU2003209534A8 (en) 2003-09-22
WO2003077829A3 (en) 2003-12-04
WO2003075825A3 (en) 2003-11-13
AU2003208505A8 (en) 2003-09-29
AU2003209534A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
EP1543034A4 (en) Treatment and prophylaxis with 4-1bb-binding agents
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1476150A4 (en) Carboxyfullerenes and methods of use thereof
GB0220214D0 (en) Compounds and their use
GB0213869D0 (en) The treatment of pain
GB0615918D0 (en) Composition and its therapeutic use
GB0223570D0 (en) Surface treatment
GB0207410D0 (en) Compounds and their therapeutic use
EP1558238A4 (en) Beta-hydroxyphenylaldylamines and their use for treating glaucoma
SG110107A1 (en) Compound and use in treatment
GB2392839A8 (en) Use of Mycobacterium w in the treatment of tubercolosis
IL164951A0 (en) The treatment of pain with lfendropil
EP1683765A4 (en) Water treatment unit and equipment having the unit
EP1569928A4 (en) Therapeutic compounds and methods
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB2386839B (en) Apparatus for use in the treatment of choanal atresia
IL174968A0 (en) The use of ifenprodil in the treatment of pain
GB0211297D0 (en) Pain treatment
GB0218031D0 (en) Compounds and their use
AU2003263224A8 (en) Polishing composition and methods
GB0215773D0 (en) Compunds and their therapeutic use
GB0325957D0 (en) The treatment of pain
GB0220215D0 (en) Compounds and their use
GB0223779D0 (en) Use and process
GB0325598D0 (en) Compound and use in treatment

Legal Events

Date Code Title Description
713D Proc. under sect. 13(1) pat. act 1977 ** appl. filed
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
713F Application for mention of inventor (sect. 13(1)/1977) allowed
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)